The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Counselling framework for moderate-penetrance cancer-susceptibility mutations
Open accessAbstract
The use of multigene panels for the assessment of cancer susceptibility is expanding rapidly in clinical practice, particularly in the USA, despite concerns regarding the uncertain clinical validity for some gene variants and the uncertain clinical utility of most multigene panels. So-called 'moderate-penetrance' gene mutations associated with cancer susceptibility are identified in approximately 2–5% of individuals referred for clinical testing; some of these mutations are potentially actionable. Nevertheless, the appropriate management of individuals harbouring such moderate-penetrance genetic variants is unclear. The cancer risks associated with mutations in moderate-penetrance genes are lower and different than those reported for high-penetrance gene mutations (such as mutations in BRCA1 and BRCA2, and those associated with Lynch syndrome). The extrapolation of guidelines for the management of individuals with high-penetrance variants of cancer-susceptibility genes to the clinical care of patients with moderate-penetrance gene mutations could result in substantial harm. Thus, we provide a framework for clinical decision-making pending the development of a sufficient evidence base to document the clinical utility of the interventions for individuals with inherited moderate-penetrance gene mutations associated with an increased risk of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The National Comprehensive Cancer Network: Present and future directions
McGivney, W. T. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980515)82:10+<2057::aid-cncr14>3.0.co;2-a · Cited by 16,766
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
Saslow, D., Boetes, C., Burke, W., Harms, S., Leach, M. O., Lehman, C. D., Morris, E., Pisano, E., Schnall, M., Sener, S., et al. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.2.75 · Cited by 2,637
Domchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Self-citationJacobs, I. J., Menon, U., Ryan, A., Gentry-Maharaj, A., Burnell, M., Kalsi, J. K., Amso, N. N., Apostolidou, S., Benjamin, E., Cruickshank, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01224-6 · Cited by 1,048
Walsh, T., Casadei, S., Lee, M. K., Pennil, C. C., Nord, A. S., Thornton, A. M., Roeb, W., Agnew, K. J., Stray, S. M., Wickramanayake, A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115052108 · Cited by 933
Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
Easton, D. F., Pharoah, P. D. P., Antoniou, A. C., Tischkowitz, M., Tavtigian, S. V., Nathanson, K. L., Devilee, P., Meindl, A., Couch, F. J., Southey, M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1501341 · Cited by 920
Self-citationBreast-Cancer Risk in Families with Mutations in PALB2
Antoniou, A. C., Casadei, S., Heikkinen, T., Barrowdale, D., Pylkäs, K., Roberts, J., Lee, A., Subramanian, D., De Leeneer, K., Fostira, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1400382 · Cited by 851
Self-citationInherited Mutations in Women With Ovarian Carcinoma
Norquist, B. M., Harrell, M. I., Brady, M. F., Walsh, T., Lee, M. K., Gulsuner, S., Bernards, S. S., Casadei, S., Yi, Q., Burger, R. A., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5495 · Cited by 769
A systematic review and meta-analysis of familial colorectal cancer risk
Johns, L. E., & Houlston, R. S. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04677.x · Cited by 722
Couch, F. J., Hart, S. N., Sharma, P., Toland, A. E., Wang, X., Miron, P., Olson, J. E., Godwin, A. K., Pankratz, V. S., Olswold, C., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.1414 · Cited by 672
Self-citationSystematic Review: Using Magnetic Resonance Imaging to Screen Women at High Risk for Breast Cancer
Warner, E., Messersmith, H., Causer, P., Eisen, A., Shumak, R., & Plewes, D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-9-200805060-00007 · Cited by 564
Cancer Risks and Mortality in Heterozygous ATM Mutation Carriers
Thompson, D., Duedal, S., Kirner, J., McGuffog, L., Last, J., Reiman, A., Byrd, P., Taylor, M., & Easton, D. F. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji141 · Cited by 543
Germline mutations in RAD51D confer susceptibility to ovarian cancer
Breast Cancer Susceptibility Collaboration (UK), Loveday, C., Turnbull, C., Ramsay, E., Hughes, D., Ruark, E., Frankum, J. R., Bowden, G., Kalmyrzaev, B., Warren-Perry, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.893 · Cited by 534
ATM Mutations in Patients with Hereditary Pancreatic Cancer
Roberts, N. J., Jiao, Y., Yu, J., Kopelovich, L., Petersen, G. M., Bondy, M. L., Gallinger, S., Schwartz, A. G., Syngal, S., Cote, M. L., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0194 · Cited by 491
Clinical Evaluation of a Multiple-Gene Sequencing Panel for Hereditary Cancer Risk Assessment
Kurian, A. W., Hare, E. E., Mills, M. A., Kingham, K. E., McPherson, L., Whittemore, A. S., McGuire, V., Ladabaum, U., Kobayashi, Y., Lincoln, S. E., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.6607 · Cited by 485
(2004) · The American Journal of Human Genetics · doi:10.1086/421251 · Cited by 471
Breast Cancer Screening and Diagnosis
Bevers, T. B., Anderson, B. O., Bonaccio, E., Buys, S., Daly, M. B., Dempsey, P. J., Farrar, W. B., Fleming, I., Garber, J. E., Harris, R. E., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0070 · Cited by 465
Self-citationGermline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
Ramus, S. J., Song, H., Dicks, E., Tyrer, J. P., Rosenthal, A. N., Intermaggio, M. P., Fraser, L., Gentry-Maharaj, A., Hayward, J., Philpott, S., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv214 · Cited by 437
Tung, N., Battelli, C., Allen, B., Kaldate, R., Bhatnagar, S., Bowles, K., Timms, K., Garber, J. E., Herold, C., Ellisen, L., et al. (2015) · Cancer · doi:10.1002/cncr.29010 · Cited by 430
Self-citationMutations in BRIP1 confer high risk of ovarian cancer
Rafnar, T., Gudbjartsson, D. F., Sulem, P., Jonasdottir, A., Sigurdsson, A., Jonasdottir, A., Besenbacher, S., Lundin, P., Stacey, S. N., Gudmundsson, J., et al. (2011) · Nature Genetics · doi:10.1038/ng.955 · Cited by 406
ACR Appropriateness Criteria Breast Cancer Screening
Mainiero, M. B., Lourenco, A., Mahoney, M. C., Newell, M. S., Bailey, L., Barke, L. D., D'Orsi, C., Harvey, J. A., Hayes, M. K., Huynh, P. T., et al. (2013) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2012.09.036 · Cited by 342
Desmond, A., Kurian, A. W., Gabree, M., Mills, M. A., Anderson, M. J., Kobayashi, Y., Horick, N., Yang, S., Shannon, K. M., Tung, N., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2690 · Cited by 333
Self-citationLaDuca, H., Stuenkel, A. J., Dolinsky, J. S., Keiles, S., Tandy, S., Pesaran, T., Chen, E., Gau, C.-L., Palmaer, E., Shoaepour, K., et al. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.40 · Cited by 332
Song, H., Dicks, E., Ramus, S. J., Tyrer, J. P., Intermaggio, M. P., Hayward, J., Edlund, C. K., Conti, D., Harrington, P., Fraser, L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.2408 · Cited by 328
Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients With Pancreatic Cancer
Grant, R. C., Selander, I., Connor, A. A., Selvarajah, S., Borgida, A., Briollais, L., Petersen, G. M., Lerner-Ellis, J., Holter, S., & Gallinger, S. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.11.042 · Cited by 299
BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study
Zhen, D. B., Rabe, K. G., Gallinger, S., Syngal, S., Schwartz, A. G., Goggins, M. G., Hruban, R. H., Cote, M. L., McWilliams, R. R., Roberts, N. J., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.153 · Cited by 295
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015
Daly, M. B., Pilarski, R., Axilbund, J. E., Berry, M., Buys, S. S., Crawford, B., Farmer, M., Friedman, S., Garber, J. E., Khan, S., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0018 · Cited by 292
Self-citationWarner, E., Hill, K., Causer, P., Plewes, D., Jong, R., Yaffe, M., Foulkes, W. D., Ghadirian, P., Lynch, H., Couch, F., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0835 · Cited by 280
Self-citationYurgelun, M. B., Allen, B., Kaldate, R. R., Bowles, K. R., Judkins, T., Kaushik, P., Roa, B. B., Wenstrup, R. J., Hartman, A.-R., & Syngal, S. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.006 · Cited by 260
Germline RAD51C mutations confer susceptibility to ovarian cancer
Breast Cancer Susceptibility Collaboration (BCSC) (UK), Loveday, C., Turnbull, C., Ruark, E., Xicola, R. M. M., Ramsay, E., Hughes, D., Warren-Perry, M., Snape, K., Eccles, D., et al. (2012) · Nature Genetics · doi:10.1038/ng.2224 · Cited by 252
Multiplex Genetic Testing for Cancer Susceptibility: Out on the High Wire Without a Net?
Domchek, S. M., Bradbury, A., Garber, J. E., Offit, K., & Robson, M. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.9403 · Cited by 237
Self-citationKing, T. A., Pilewskie, M., Muhsen, S., Patil, S., Mautner, S. K., Park, A., Oskar, S., Guerini-Rocco, E., Boafo, C., Gooch, J. C., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.4743 · Cited by 208
Lincoln, S. E., Kobayashi, Y., Anderson, M. J., Yang, S., Desmond, A. J., Mills, M. A., Nilsen, G. B., Jacobs, K. B., Monzon, F. A., Kurian, A. W., et al. (2015) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.04.009 · Cited by 205
Germline RECQL mutations are associated with breast cancer susceptibility
Cybulski, C., Carrot-Zhang, J., Kluźniak, W., Rivera, B., Kashyap, A., Wokołorczyk, D., Giroux, S., Nadaf, J., Hamel, N., Zhang, S., et al. (2015) · Nature Genetics · doi:10.1038/ng.3284 · Cited by 189
Weischer, M., Nordestgaard, B. G., Pharoah, P., Bolla, M. K., Nevanlinna, H., van't Veer, L. J., Garcia-Closas, M., Hopper, J. L., Hall, P., Andrulis, I. L., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.7336 · Cited by 181
Self-citationLoss-of-function variants in ATM confer risk of gastric cancer
Helgason, H., Rafnar, T., Olafsdottir, H. S., Jonasson, J. G., Sigurdsson, A., Stacey, S. N., Jonasdottir, A., Tryggvadottir, L., Alexiusdottir, K., Haraldsson, A., et al. (2015) · Nature Genetics · doi:10.1038/ng.3342 · Cited by 180
Maxwell, K. N., Wubbenhorst, B., D’Andrea, K., Garman, B., Long, J. M., Powers, J., Rathbun, K., Stopfer, J. E., Zhu, J., Bradbury, A. R., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.176 · Cited by 159
Self-citationBernstein, J. L., Haile, R. W., Stovall, M., Boice, J. D., Shore, R. E., Langholz, B. M., Thomas, D. C., Bernstein, L., Lynch, C. F., Olsen, J. H., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq055 · Cited by 151
Shaag, A., Walsh, T., Renbaum, P., Kirchhoff, T., Nafa, K., Shiovitz, S., Mandell, J. B., Welcsh, P. L., Lee, M. K., Ellis, N. A., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi052 · Cited by 143
Self-citationNäslund‐Koch, C., Nordestgaard, B. G., & Bojesen, S. E. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.3594 · Cited by 141
Ma, X., Zhang, B., & Zheng, W. (2013) · Gut · doi:10.1136/gutjnl-2012-304121 · Cited by 140
Coopey, S. B., Mazzola, E., Buckley, J. M., Sharko, J., Bellı, A. K., Kim, E. M. H., Polubriaginof, F. C. G., Parmigiani, G., Garber, J. E., Smith, B. L., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2318-8 · Cited by 137
Self-citationHereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2
Minion, L. E., Dolinsky, J. S., Chase, D. M., Dunlop, C. L. M., Chao, E., & Monk, B. J. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.01.537 · Cited by 121
Bernstein, J. L., Teraoka, S. N., Southey, M. C., Jenkins, M. A., Andrulis, I. L., Knight, J. A., John, E. M., Lapinski, R. H., Wolitzer, A. L., Whittemore, A. S., et al. (2006) · Human Mutation · doi:10.1002/humu.20415 · Cited by 118
A PALB2 mutation associated with high risk of breast cancer
Southey, M. C., Teo, Z. L., Dowty, J. G., Odefrey, F., Park, D. J., Tischkowitz, M. D., Sabbaghian, N., Apicella, C., Byrnes, G. B., Winship, I., et al. (2010) · Breast Cancer Research · doi:10.1186/bcr2796 · Cited by 118
Easton, D. F., Lesueur, F., Decker, B. J., Michailidou, K., Li, J., Allen, J., Luccarini, C., Pooley, K. A., Shah, M., Bolla, M. K., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103529 · Cited by 109
The Effect of CHEK2 Variant I157T on Cancer Susceptibility: Evidence from a Meta-Analysis
Han, F., Guo, C., & Liu, L. (2013) · DNA and Cell Biology · doi:10.1089/dna.2013.1970 · Cited by 98
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)
Saadatmand, S., Obdeijn, I., Rutgers, E. J., Oosterwijk, J. C., Tollenaar, R. A., Woldringh, G. H., Bergers, E., Verhoef, C., Heijnsdijk, E. A., Hooning, M. J., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29534 · Cited by 96
Heijnsdijk, E. A. M., Warner, E., Gilbert, F. J., Tilanus‐Linthorst, M. M. A., Evans, D. G., Causer, P. A., Eeles, R. A., Kaas, R., Draisma, G., Ramsay, E. A., et al. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-1196 · Cited by 95
Jervis, S., Song, H., Lee, A., Dicks, E., Tyrer, J. P., Harrington, P. A., Easton, D. F., Jacobs, I. J., Pharoah, P. D. P., & Antoniou, A. C. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-102015 · Cited by 93
APC Polymorphisms and the Risk of Colorectal Neoplasia: A HuGE Review and Meta-Analysis
Liang, J., Lin, C., Hu, F., Wang, F., Zhu, L., Yao, X., Wang, Y., & Zhao, Y. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws382 · Cited by 87
CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women
Adank, M. A., Jonker, M. A., Kluijt, I., van Mil, S. E., Oldenburg, R. A., Mooi, W. J., Hogervorst, F. B. L., van den Ouweland, A. M. W., Gille, J. J. P., Schmidt, M. K., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100380 · Cited by 76
Zhang, G., Zeng, Y., Liu, Z., & Wei, W. (2013) · Tumor Biology · doi:10.1007/s13277-013-0830-z · Cited by 70
Rare Mutations in RINT1 Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
Park, D. J., Tao, K., Calvez‐Kelm, F. L., Nguyen‐Dumont, T., Robinot, N. R., Hammet, F., Odefrey, F., Tsimiklis, H., Teo, Z. L., Thingholm, L. B., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0212 · Cited by 52
Quante, A. S., Whittemore, A. S., Shriver, T., Hopper, J. L., Strauch, K., & Terry, M. B. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv124 · Cited by 49
Variants in the ATM Gene Associated with a Reduced Risk of Contralateral Breast Cancer
CONCANNON, P. J., Haile, R. W., Børresen‐Dale, A., Rosenstein, B. S., Gatti, R. A., Teraoka, S. N., Diep, A. T., Jansen, L., Atencio, D. P., Langholz, B. M., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0134 · Cited by 48
Time to Check CHEK2 in Families With Breast Cancer?
Offit, K., & Garber, J. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8503 · Cited by 44
Self-citationCHEK2*1100delC homozygosity in the Netherlands—prevalence and risk of breast and lung cancer
Huijts, P. E. A., Hollestelle, A., Balliu, B., Houwing‐Duistermaat, J. J., Meijers, C. M., Blom, J., Ozturk, B., Krol-Warmerdam, E. M., Wijnen, J., Berns, E. M. J. J., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.85 · Cited by 38
Analysis of CHEK2 gene for ovarian cancer susceptibility
Baysal, B. E., DeLoia, J. A., Willett-Brozick, J. E., Goodman, M. T., Brady, M. F., Modugno, F., Lynch, H. T., Conley, Y. P., Watson, P. A., & Gallion, H. H. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.07.015 · Cited by 35
Adank, M. A., Verhoef, S., Oldenburg, R. A., Schmidt, M. K., Hooning, M. J., Martens, J. W. M., Broeks, A., Rookus, M. A., Waisfisz, Q., Lissenberg-Witte, B. I., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2013.01.009 · Cited by 26
Cited by
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
Daly, M. B., Pilarski, R., Berry, M., Buys, S. S., Farmer, M., Friedman, S., Garber, J. E., Kauff, N. D., Khan, S., Klein, C., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0003 · Cited by 650
Self-citationCancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer
Yurgelun, M. B., Kulke, M. H., Fuchs, C. S., Allen, B. A., Uno, H., Hornick, J. L., Ukaegbu, C. I., Brais, L. K., McNamara, P. G., Mayer, R. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.0012 · Cited by 524
Daly, M. B., Pilarski, R., Yurgelun, M. B., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., Elkhanany, A., Friedman, S., Garber, J. E., et al. (2020) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2020.0017 · Cited by 505
Self-citationDeleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma
Shindo, K., Yu, J., Suenaga, M., Fesharakizadeh, S., Cho, C., Macgregor-Das, A., Siddiqui, A., Witmer, P. D., Tamura, K., Song, T. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.3502 · Cited by 458
Yang, X., Leslie, G., Doroszuk, A., Schneider, S., Allen, J., Decker, B., Dunning, A. M., Redman, J., Scarth, J., Plaskocinska, I., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01907 · Cited by 432
Self-citation
Metadata
- Authors
- Tung, N., Domchek, S. M., Stadler, Z., Nathanson, K. L., Couch, F., Garber, J. E., Offit, K., & Robson, M. E.
- Venue
- Nature Reviews Clinical Oncology
- Published
- 2016-06-14
- Volume
- 13
- Issue
- 9
- Pages
- 581-588
- ISSN
- 1759-4774 (ISSN-L)
- 1759-4782
- OpenAlex
- W2425061965
- Cited by
- 314
- References
- 63
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.